IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index
November 12 2020 - 3:36PM
Business Wire
Annualized 2020 Return Since IBBJ’s Launch is
100.87% vs Nasdaq Biotech TR Index 5.77%
IBBJ 20.83% (since inception) vs. Nasdaq
Biotechnology TR Index 1.53%
About Defiance: Founded in 2018, Defiance ETFs is an
exchange-traded funds (ETFs) sponsor and registered investment
advisor, focused on thematic investing. Defiance’s organic growth,
driven by our innovative first-mover ETFs and cutting-edge digital
footprint, has made Defiance into one of the most dynamic
investment brands. Our suite of rules-based ETFs allows retail
investors, financial advisors and institutions to express a
targeted view on subsectors that are leading the way in disruptive
innovations. Defiance’s growth and digital reach in asset
management is powered by its proprietary digital marketing
technology, Defiance Analytics LLC. Analytics utilizes machine
learning and natural language processing to enhance investors’
digital experience around product research and content.
Index Description: The Nasdaq Junior Biotechnology Index is
designed to track the performance of a set of securities that are
classified as either biotechnology or pharmaceutical. To be
eligible for inclusion in the Index, a security must meet the
following criteria: 1) Be a member of the Nasdaq Biotechnology
Index. 2) Have a market capitalization that is less than $5 billion
as of the reference date of the annual evaluation.
Performance as of 11/11/2020. Performance since Inception of
IBBJ: 8/4/2020. Source: Bloomberg.
For additional information, please visit www.DefianceETFs.com or
call 1-833-333-9383.
The performance data quoted represents past performance. Past
performance does not guarantee future results. The investment
return and principal value of an investment will fluctuate so that
an investor's shares, when sold or redeemed, may be worth more or
less than their original cost and current performance may be lower
or higher than the performance quoted. Performance current to the
most recent month-end can be obtained by calling 833.333.9383 or by
going to this link: https://www.defianceetfs.com/ibbj. Short
term performance, in particular, is not a good indication of the
fund's future performance, and an investment should not be made
based solely on returns.
The Fund’s investment objectives, risks, charges, and expenses
must be considered carefully before investing. The prospectus and
summary prospectus contain this and other important information
about the investment company. The prospectus can be obtained by
calling 1-833-333-9383 Please read it carefully before
investing.
Investing involves risk. Principal loss is possible.
A commission may apply when buying or selling an ETF.
The Fund is new with a limited operating history.
Defiance ETFs are distributed by Foreside Fund Services,
LLC.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201112006046/en/
David Hanono Defiance ETFs 1-833-333-9393
info@defianceetfs.com
Defiance Nasdaq Junior B... (NASDAQ:IBBJ)
Historical Stock Chart
From Sep 2024 to Oct 2024
Defiance Nasdaq Junior B... (NASDAQ:IBBJ)
Historical Stock Chart
From Oct 2023 to Oct 2024